Background Head and Neck Squamous Cell Carcinoma (HNSCC) is recognized for its heterogeneous nature, leading to varied responses to existing therapeutic regimens. The objective of this study is to provide a comprehensive overview of the molecular characteristics identified thus far in HNSCC and, specifically, to explore target molecules for personalized therapies.
No takes yet. Share an insight, caveat, or question.
Kourou et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: